Feasibility
|
It is well known how important are the results of feasibility for timely enrollment and success of the whole study. We use our expertise in sites selection process to assess all aspects of proposed study, including regulatory issues, epidemiology, limitations of enrollment, challenges with logistics of importation of different clinical trial materials, timelines for approval by regulatory bodies. To get reliable perspectives of the study in Russia and Ukraine, our feasibility approach relies on personal relationships and communication with investigators, rather than on fast distribution of questionnaires via email/fax. We also have experience in organization of protocol draft review by key opinion leaders in Russia and Ukraine, which allows clients to get independent feedback from scientific and practical point of view at an early stage of protocol development. If you would like to conduct a feasibility study, just This e-mail address is being protected from spambots. You need JavaScript enabled to view it or call Dr. Vladimir Krechikov. |
News and messages from CEO,
Dr Vladimir Bogin
12.01.2012 |
Cromos Pharma has participated in the conference on clinical trials in emerging markets in Tel-Aviv, Israel on 11 January 2012. [...] |
05.01.2012 |
Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012. [...] |
14.12.2011 |
Cromos Pharma published a white paper with review of Russian clinical trials market in 2011. [...] |
28.10.2011 |
Cromos Pharma's CEO, Dr. Vladimir Bogin has participated in the annual Rusnanotech forum in Moscow, Russia on 25-28 October 2011 . [...] |
27.09.2011 |
Meet us at 17th Annual International Partnering Conference BIO-Europe 2011 in Duesseldorf, Germany on 31 October - 02 November 2011. [...] |


